Difference between revisions of "Markovic 2019 MiP2019"
From Bioblast
| Line 9: | Line 9: | ||
|editor=[[Plangger M]], [[Tindle-Solomon L]] | |editor=[[Plangger M]], [[Tindle-Solomon L]] | ||
}} | }} | ||
{{Labeling}} | {{Labeling | ||
|area=Pharmacology;toxicology | |||
|diseases=Parkinson's | |||
}} | |||
== Affiliations == | == Affiliations == | ||
::::Ivanka Marković(1), Maja Jovanović(1), Marija Dulović(1), Marija Jeremić(1), Ljubica Harhaji-Trajković(3), Vladimir Kostić(2) and Vladimir Trajković(3) | ::::Ivanka Marković(1), Maja Jovanović(1), Marija Dulović(1), Marija Jeremić(1), Ljubica Harhaji-Trajković(3), Vladimir Kostić(2) and Vladimir Trajković(3) | ||
Revision as of 13:38, 3 October 2019
| Targeting energy-sensing pathways as possible neuroprotective strategy in neurodegenerative disorders. |
Link: MiP2019
Markovic I, Jovanovic M, Dulovic M, Jeremic M, Harhaji-Trajkovic L, Kostic V, Trajkovic V (2019)
Event: MiP2019
At the request of the author, this abstract is not made available online.
• Bioblast editor: Plangger M, Tindle-Solomon L
Labels: MiParea: Pharmacology;toxicology Pathology: Parkinson's
Affiliations
- Ivanka Marković(1), Maja Jovanović(1), Marija Dulović(1), Marija Jeremić(1), Ljubica Harhaji-Trajković(3), Vladimir Kostić(2) and Vladimir Trajković(3)
- Inst Medical Clinical Biochemistry, Fac Medicine
- Inst Biological Research “Siniša Stanković”
- Clinic Neurology, Fac Medicine
- Inst Microbiology Immunology, Fac Medicine; Univ Belgrade, Serbia
- Ivanka Marković(1), Maja Jovanović(1), Marija Dulović(1), Marija Jeremić(1), Ljubica Harhaji-Trajković(3), Vladimir Kostić(2) and Vladimir Trajković(3)
